ScholarX

Journal of Clinical Oncology

Journal Title

  • Journal of Clinical Oncology

ISSN

  • E 1527-7755 | P 0732-183X

Publisher

  • American Society of Clinical Oncology

Listed on(Coverage)

JCR 1997-2023
SJR 1999-2020;2022-2023
CiteScore 2011-2023
SCI 2010-2019
SCIE 2010-2024
CC 2016-2024
SCOPUS 2017-2024
MEDLINE 2016-2024
EMBASE 2016-2024

Active

  • Active

    based on the information

    • SCOPUS:2024-10

Country

  • USA

Aime & Scopes

  • JCO publishes original research, reviews and other material related to breast cancer, gastrointestinal cancer, hematologic malignancies, molecular oncology, lung cancer, genitourinary cancer, head and neck cancer, pediatric oncology, neurooncology, supportive care and quality of life issues, prevention, and phase I and clinical pharmacology. Its readership comprises practicing clinical oncologists, researchers, students, individuals in training, and allied health professionals throughout the world. Members of the American Society of Clinical Oncology as well as nonmember subscribers and patrons of medical libraries globally utilize the groundbreaking research published in each issue of JCO.

Homepage

Article List

61 - 80 out of 1,009 results.

SCIESCOPUS
Subcutaneous amivantamab (ami) in patients (pts) with advanced solid malignancies: The PALOMA study-Updated safety and identification of the recommended phase 2 dose

Minchom, AR[Minchom, Anna Rachel]; Krebs, MG[Krebs, Matthew G.]; Cho, BC[Cho, Byoung Chul]; Lee, SH[Lee, Se-Hoon]; Leighl, NB[Leighl, Natasha B.]; O'Neil, B[O'Neil, Bert]; Sabari, JK[Sabari, Joshua K.]; Kudgus-Lokken, R[Kudgus-Lokken, Rachel]; Alhadab, A[Alhadab, Ali]; Haddish-Berhane, N[Haddish-Berhane, Nahor], et al.

ArticleIssue Date2023CitationJOURNAL OF CLINICAL ONCOLOGY, v.41, no.16PublisherLIPPINCOTT WILLIAMS & WILKINS
SCIESCOPUS
An age-specific pooled analysis of trastuzumab deruxtecan (T-DXd) in patients (pts) with HER2-positive (HER2+) metastatic breast cancer (mBC) from DESTINY-Breast01,-02, and-03

Krop, IE[Krop, Ian E.]; Wildiers, H[Wildiers, Hans]; Hurvitz, SA[Hurvitz, Sara A.]; Cortes, J[Cortes, Javier]; Im, SA[Im, Seock-Ah]; Iwata, H[Iwata, Hiroji]; Andre, F[Andre, Fabrice]; Saura, C[Saura, Cristina]; Modi, S[Modi, Shanu]; Kim, SB[Kim, Sung-Bae], et al.

ArticleIssue Date2023CitationJOURNAL OF CLINICAL ONCOLOGY, v.41, no.16PublisherLIPPINCOTT WILLIAMS & WILKINS
SCIESCOPUS
Alpelisib plus endocrine therapy in patients with PIK3CA-mutated, hormone receptor-positive, human epidermal growth factor receptor 2-negative, advanced breast cancer: Analysis of all 3 cohorts of the BYLieve study

Chia, S[Chia, Stephen]; Neven, P[Neven, Patrick]; Ciruelos, EM[Ciruelos, Eva M.]; Lerebours, F[Lerebours, Florence]; Ruiz-Borrego, M[Ruiz-Borrego, Manuel]; Drullinsky, P[Drullinsky, Pamela]; Prat, A[Prat, Aleix]; Park, YH[Park, Yeon Hee]; Juric, D[Juric, Dejan]; Turner, NC[Turner, Nicholas C.], et al.

ArticleIssue Date2023CitationJOURNAL OF CLINICAL ONCOLOGY, v.41, no.16PublisherLIPPINCOTT WILLIAMS & WILKINS
SCIESCOPUS
A first-in-human, open-label, dose escalation and expansion study of orally administered NX-019 in patients with advanced EGFR mutant cancer.

Spira, AI[Spira, Alexander I.]; Kim, DW[Kim, Dong-Wan]; Ahn, MJ[Ahn, Myung-Ju]; Kim, SW[Kim, Sang-We]; Hong, MH[Hong, Min Hee]; Dusek, R[Dusek, Rachel]; Gammon, GM[Gammon, Guy M.]; Wilson, K[Wilson, Keith]; Yang, JCH[Yang, James Chih-Hsin]; Massarelli, E[Massarelli, Erminia]

ArticleIssue Date2023CitationJOURNAL OF CLINICAL ONCOLOGY, v.41, no.16PublisherLIPPINCOTT WILLIAMS & WILKINS
SCIESCOPUS
Investigating the novel CD16A and epidermal growth factor receptor (EGFR) bispecific innate cell engager, AFM24, to leverage the innate immune system: Interim results from the colorectal cancer (CRC) cohort

Cervantes, A[Cervantes, Andres]; Rivas, D[Rivas, Delcia]; Lee, SH[Lee, Se-Hoon]; Thomas, JS[Thomas, Jacob Stephen]; Kim, YJ[Kim, Yu Jung]; Saavedra, O[Saavedra, Omar]; Shim, BY[Shim, Byoung Yong]; Kohlhas, L[Kohlhas, Laura]; Hintzen, G[Hintzen, Gabriele]; Emig, M[Emig, Michael], et al.

ArticleIssue Date2023CitationJOURNAL OF CLINICAL ONCOLOGY, v.41, no.16PublisherLIPPINCOTT WILLIAMS & WILKINS
SCIESCOPUS
Prospective single-arm study of endocrine therapies with ovarian function suppression in premenopausal patients with node-positive early breast cancer with low genomic risk (INTERSTELLAR trial, KBCSG-25)

Ahn, SG[Ahn, Sung Gwe]; Kook, Y[Kook, Yoonwon]; Moon, HG[Moon, Hyeong-Gon]; Lee, JE[Lee, Jeong Eon]; Ahn, JH[Ahn, Jee Hyun]; Chae, H[Chae, Heejung]; Lee, J[Lee, Jeeyeon]; Park, MH[Park, Min Ho]; Yoon, CI[Yoon, Chang Ik]; Kang, T[Kang, Taewoo], et al.

ArticleIssue Date2023CitationJOURNAL OF CLINICAL ONCOLOGY, v.41, no.16PublisherLIPPINCOTT WILLIAMS & WILKINS
SCIESCOPUS
MagnetisMM-7: An open-label, multicenter, randomized phase 3 study of elranatamab versus lenalidomide in post-transplant patients with newly diagnosed multiple myeloma.

Manteca, MVM[Manteca, Maria Victoria Mateos]; Grosicki, S[Grosicki, Sebastian]; Kim, K[Kim, Kihyun]; Negre, E[Negre, Eric]; Vandendries, E[Vandendries, Erik]

ArticleIssue Date2023CitationJOURNAL OF CLINICAL ONCOLOGY, v.41, no.16PublisherLIPPINCOTT WILLIAMS & WILKINS
SCIESCOPUS
Immune phenotype-driven treatment outcome of IO-only versus chemo-IO in PD-L1-high, first-line, advanced non-small cell lung cancer (NSCLC)

Park, S[Park, Sehhoon]; Jung, HA[Jung, Hyun Ae]; Sun, JM[Sun, Jong-Mu]; Choi, YL[Choi, Yoon-La]; Lee, SH[Lee, Se-Hoon]; Ahn, JS[Ahn, Jin Seok]; Ahn, MJ[Ahn, Myung-Ju]; Oum, C[Oum, Chiyoon]; Shin, S[Shin, Seunghwan]; Lim, Y[Lim, Yoojoo], et al.

ArticleIssue Date2023CitationJOURNAL OF CLINICAL ONCOLOGY, v.41, no.16PublisherLIPPINCOTT WILLIAMS & WILKINS
SCIESCOPUS
Triplet maintenance (olaparib, pembrolizumab, and bevacizumab) in BRCA non-mutated patients with platinum-sensitive recurrent ovarian cancer: A multi-center, single-arm phase II study (OPEB-01)

Kim, YN[Kim, Yoo Na]; Park, B[Park, Boram]; Joung, JG[Joung, Je-Gun]; Kim, JW[Kim, Jae-Weon]; Kim, BG[Kim, Byoung-Gie]; Kim, SW[Kim, Sang Wun]; Kim, HS[Kim, Hee Seung]; Choi, CH[Choi, Chel Hun]; Lim, MC[Lim, Myong Cheol]; Ngoi, NY[Ngoi, Natalie Yl], et al.

ArticleIssue Date2023CitationJOURNAL OF CLINICAL ONCOLOGY, v.41, no.16PublisherLIPPINCOTT WILLIAMS & WILKINS
SCIESCOPUS
Transcriptomic subtype, TP53 mutation status, and APOBEC mutation signature in early-stage EGFR-mutant non-small-cell lung cancer

Jung, HA[Jung, Hyun Ae]; Lim, J[Lim, Jinyeong]; Choi, YL[Choi, Yoon-La]; Park, S[Park, Sehhoon]; Sun, JM[Sun, Jong-Mu]; Ahn, JS[Ahn, Jin Seok]; Ahn, MJ[Ahn, Myung-Ju]; Lee, SH[Lee, Se-Hoon]

ArticleIssue Date2023CitationJOURNAL OF CLINICAL ONCOLOGY, v.41, no.16PublisherLIPPINCOTT WILLIAMS & WILKINS
SCIESCOPUS
Comprehensive geriatric assessment based multidisciplinary team intervention for hospitalized frail patients in oncology: COMPASS-ONCO/KCSG AL21-13

Lee, YG[Lee, Yun-Gyoo]; Hwang, IG[Hwang, In Gyu]; Koh, SJ[Koh, Su-Jin]; Hong, S[Hong, Soojung]; Kim, JW[Kim, Jin Won]; Kim, JH[Kim, Jee Hyun]

ArticleIssue Date2023CitationJOURNAL OF CLINICAL ONCOLOGY, v.41, no.16PublisherLIPPINCOTT WILLIAMS & WILKINS
SCIESCOPUS
Comparison of efficacy between immune checkpoint inhibitors and irinotecan-based chemotherapy as third-line treatment for patients with advanced gastric cancer: A Korean real-world multicenter study (KCSG ST22-06)

Lim, SH[Lim, Sung Hee]; Kim, JJ[Kim, Jae-Joon]; Im, HS[Im, Hyeon-Su]; Han, HS[Han, Hye Sook]; Kim, IH[Kim, In-Ho]; Koo, DH[Koo, Dong-Hoe]; Cho, JH[Cho, Jang Ho]; Maeng, CH[Maeng, Chi Hoon]; Lee, MY[Lee, Min-Young]; Lee, HJ[Lee, Hyo Jin], et al.

ArticleIssue Date2023CitationJOURNAL OF CLINICAL ONCOLOGY, v.41, no.16PublisherLIPPINCOTT WILLIAMS & WILKINS
SCIESCOPUS
Neoadjuvant docetaxel, oxaliplatin, and s-1 plus surgery and adjuvant s-1 for resectable advanced gastric cancer: Final survival outcomes of the randomized phase 3 PRODIGY trial

Kang, YK[Kang, Yoon-Koo]; Kim, HD[Kim, Hyung-Don]; Yook, JH[Yook, Jeong Hwan]; Park, YK[Park, Young-Kyu]; Kim, YW[Kim, Young-Woo]; Kim, JY[Kim, Jin Young]; Ryu, MH[Ryu, Min-Hee]; Rha, SY[Rha, Sun Young]; Chung, IJ[Chung, Ik-Joo]; Kim, IH[Kim, In-Ho], et al.

ArticleIssue Date2023CitationJOURNAL OF CLINICAL ONCOLOGY, v.41, no.16PublisherLIPPINCOTT WILLIAMS & WILKINS
SCIESCOPUS
KEYNOTE-859 study of pembrolizumab plus chemotherapy for advanced HER2-negative gastric or gastroesophageal junction (G/GEJ) cancer: Outcomes in the protocol-specified PD-L1-selected populations

Rha, SY[Rha, Sun Young]; Wyrwicz, L[Wyrwicz, Lucjan]; Weber, PEY[Weber, Patricio Eduardo Yanez]; Bai, YX[Bai, Yuxian]; Ryu, MH[Ryu, Min-Hee]; Lee, J[Lee, Jeeyun]; Rivera, F[Rivera, Fernando]; Alves, GV[Alves, Gustavo Vasconcelos]; Garrido, M[Garrido, Marcelo]; Shiu, KK[Shiu, Kai-Keen], et al.

ArticleIssue Date2023CitationJOURNAL OF CLINICAL ONCOLOGY, v.41, no.16PublisherLIPPINCOTT WILLIAMS & WILKINS
SCIESCOPUS
Outcomes by occurrence of immune-mediated adverse events (imAEs) with tremelimumab (T) plus durvalumab (D) in the phase 3 HIMALAYA study in unresectable hepatocellular carcinoma (uHCC)

Lau, G[Lau, George]; Cheng, AL[Cheng, Ann-Lii]; Sangro, B[Sangro, Bruno]; Kudo, M[Kudo, Masatoshi]; Kelley, RK[Kelley, Robin Kate]; Tak, WY[Tak, Won Young]; Gasbarrini, A[Gasbarrini, Antonio]; Reig, M[Reig, Maria]; Lim, HY[Lim, Ho Yeong]; Tougeron, D[Tougeron, David], et al.

ArticleIssue Date2023CitationJOURNAL OF CLINICAL ONCOLOGY, v.41, no.16PublisherLIPPINCOTT WILLIAMS & WILKINS
SCIESCOPUS
waveLINE-006: A phase 2 study of the safety and efficacy of zilovertamab vedotin as monotherapy or in combination in patients (pts) with aggressive and indolent B-cell malignancies.

Zinzani, PL[Zinzani, Pier Luigi]; Mayer, J[Mayer, Jiri]; Benjamini, O[Benjamini, Ohad]; Berkovits, A[Berkovits, Alejandro]; Glimelius, I[Glimelius, Ingrid]; Stevens, DA[Stevens, Don A.]; Chaudhry, A[Chaudhry, Arvind]; Demir, AM[Demir, Ahmet Muzaffer]; Sanz, RG[Sanz, Ramon Garcia]; Kim, WS[Kim, Won Seog], et al.

ArticleIssue Date2023CitationJOURNAL OF CLINICAL ONCOLOGY, v.41, no.16PublisherLIPPINCOTT WILLIAMS & WILKINS
SCIESCOPUS
ARTISTRY-6: Nemvaleukin alfa monotherapy in patients with advanced mucosal and cutaneous melanoma.

Weber, JS[Weber, Jeffrey S.]; Carvajal, RD[Carvajal, Richard D.]; Mehmi, I[Mehmi, Inderjit]; Kim, ST[Kim, Seung Tae]; Kim, M[Kim, Miso]; Sullivan, RJ[Sullivan, Ryan J.]; Lee, DH[Lee, Dae Ho]; Hamid, O[Hamid, Omid]; Grewal, JS[Grewal, Jaspreet Singh]; Lee, HJ[Lee, Hyo Jin], et al.

ArticleIssue Date2023CitationJOURNAL OF CLINICAL ONCOLOGY, v.41, no.16PublisherLIPPINCOTT WILLIAMS & WILKINS
SCIESCOPUS
Tucatinib and trastuzumab for previously treated HER2-positive metastatic biliary tract cancer (SGNTUC-019): A phase 2 basket study

Nakamura, Y[Nakamura, Yoshiaki]; Mizuno, N[Mizuno, Nobumasa]; Sunakawa, Y[Sunakawa, Yu]; Hamilton, EP[Hamilton, Erika P.]; Hayashi, H[Hayashi, Hidetoshi]; Kim, ST[Kim, Seung Tae]; Lee, KW[Lee, Keun-Wook]; Monk, BJ[Monk, Bradley J.]; Nguyen, D[Nguyen, Danny]; Okines, AFC[Okines, Alicia Frances Clare], et al.

ArticleIssue Date2023CitationJOURNAL OF CLINICAL ONCOLOGY, v.41, no.16PublisherLIPPINCOTT WILLIAMS & WILKINS
SCIESCOPUS
Randomized phase 3 study of first-line AZD3759 (zorifertinib) versus gefitinib or erlotinib in EGFR-mutant (EGFRm(+)) non-small-cell lung cancer (NSCLC) with central nervous system (CNS) metastasis

Wu, YL[Wu, Yi-Long]; Zhou, Q[Zhou, Qing]; Wang, J[Wang, Jie]; Yu, Y[Yu, Yan]; Xing, LG[Xing, Ligang]; Wang, Y[Wang, Ying]; Cheng, Y[Cheng, Ying]; Pan, YY[Pan, Yueyin]; Fan, Y[Fan, Yun]; Shi, JH[Shi, Jianhua], et al.

ArticleIssue Date2023CitationJOURNAL OF CLINICAL ONCOLOGY, v.41, no.16PublisherLIPPINCOTT WILLIAMS & WILKINS
SCIESCOPUS
Long-term outcomes of tepotinib in patients with MET exon 14 skipping NSCLC from the VISION study

Paik, PK[Paik, Paul K.]; Garassino, MC[Garassino, Marina Chiara]; Le, XN[Le, Xiuning]; Thomas, M[Thomas, Michael]; Sakai, H[Sakai, Hiroshi]; Veillon, R[Veillon, Remi]; Smit, EF[Smit, Egbert F.]; Mazieres, J[Mazieres, Julien]; Cortot, AB[Cortot, Alexis B.]; Raskin, J[Raskin, Jo], et al.

ArticleIssue Date2023CitationJOURNAL OF CLINICAL ONCOLOGY, v.41, no.16PublisherLIPPINCOTT WILLIAMS & WILKINS
1 2 3 4 5 6 7 8 9 10 last
STATISTICS
Total View:
Daily View:

RSS_1.0 RSS_2.0 ATOM_1.0

CONTACT US

(03063) 25-2, SUNGKYUNKWAN-RO, JONGNO-GU, SEOUL, KOREA samsunglib@skku.edu

COPYRIGHT © 2021 SUNGKYUNKWAN UNIVERSITY ALL RIGHTS RESERVED.

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

BROWSE

한국어